Vaccine Technologies: US FDA Isn’t Afraid Of Needle-Free Delivery, But It Takes Time To Develop, Woodcock Says

 
• By Derrick Gingery
  
Nasal COVID-19 vaccine formulation
A nasal COVID-19 vaccine formulation is one of several new technologies under consideration, Acting FDA Commissioner Janet Woodcock said. • Source: Alamy

More from Vaccines

More from Pink Sheet